NCT05520372View on ClinicalTrials.gov

Autologous Immune Enhancement Therapy (AIET) for Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Patients With Cancer
Interventions
COMBINATION_PRODUCT

Autologous immune enhancement therapy (AIET) for cancer patients

Autologous NK cell and CD8 T cell therapy for cancer patients

Trial Locations (1)

100000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

All Listed Sponsors
lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT05520372 - Autologous Immune Enhancement Therapy (AIET) for Cancer Patients | Biotech Hunter | Biotech Hunter